Expression of a dominant interfering mutant of MAP kinase kinase (MAPK
K) inhibits interleukin-3 (IL-3) activation of MAP kinase in the murin
e bone marrow-derived cell line BAF3. This results in an increase in t
he level of IL-3 required to stimulate cell proliferation and suppress
apoptosis. When apoptosis is constitutively inhibited by coexpression
of bcl-2, the dominant interfering MAPKK inhibits IL-3-driven cell cy
cle progression. Thus, MAPKK function is necessary for optimal IL-3 in
hibition of apoptosis and optimal IL-3 stimulation of entry into S pha
se. Expression of a constitutively activated mutant of MAPKK does not
replace IL-3, but renders cells able to proliferate in a density-depen
dent manner. Cell contact is required to allow cell proliferation; suc
h contact can be supplied by cells without activated MAPKK. (C) 1996 b
y The American Society of Hematology.